Suzy Madar specialises in intellectual property, commercial and regulatory disputes with a particular focus on technology and healthcare. She has experience working on a broad range of technology, including IT, biotechnology, pharmaceuticals, food products, consumer health products, medical devices and industrial inventions.

In particular, she has expertise advising on the regulation, pricing and reimbursement of therapeutic products, compliance with the Australian Consumer Law and public health issues (including in the context of the COVID-19 pandemic). Suzy advises clients on the enforcement of intellectual property rights and defending allegations of infringement, as well as on commercial issues relating to intellectual property.

She represents clients in the Federal Court, Supreme Court and High Court as well as in Patent Office proceedings. Suzy also provides advice in relation to transactions involving the transfer of intellectual property, health care services and pharmaceutical products.

Danny specialises in the drafting and prosecution of global patent families for chemical inventions, with a focus on the pharmaceutical/medicinal chemistry sectors. Danny’s experience covers the entire patent life cycle. He advises clients at every stage, from the patent-related aspects of experimental design, development of appropriate IP strategies and drafting patent specifications to build investable patent portfolios, to obtaining globally enforceable rights, and advising on pre-product launch infringement risks. Danny holds a PhD in organic synthetic chemistry from Monash University. During his PhD studies, Danny was awarded a Fulbright Scholarship enabling him to further his research at Harvard University. Danny has worked as a senior scientist in drug discovery in the UK pharmaceutical industry. Danny also completed a course in technology-based entrepreneurship at the Saïd Business School at Oxford University. Danny’s experience gives him a deep understanding of the journey that an invention takes from conception through to commercialisation. This allows him to identify valuable aspects of an invention and build investable patent portfolios to help his clients succeed.

Michael is a seasoned investment associate at Tenmile, with over 15 years of experience in the life sciences industry. Throughout his career, he has held a variety of positions in research, technology transfer, commercialization, and investment. Prior to joining Tenmile, Michael served as an Entrepreneur in Residence at Xora Innovation, a deep-tech venture capital firm located in Singapore. In this capacity, he evaluated new technologies developed at universities for potential spinouts.

Previously, Michael worked as the Director of Regulatory Affairs at EpiBone, a biotechnology startup based in the United States. As the first employee, he played a critical role in leading the regulatory and clinical efforts for the company's flagship product - the first stem cell-based, tissue-engineered product to reach clinical trials in the United States.

Michael's early career included software development, during which he helped develop open-source image analysis software (CellProfiler) at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts. Michael holds an MS and PhD in Biomedical Engineering from Columbia University and a BS with honors in Biomedical Engineering from Boston University.